Development of Arteannuin B Sustained-Release Microspheres for Anti-Tumor Therapy by Integrated Experimental and Molecular Modeling Approaches

Arteannuin B (AB) has been found to demonstrate obvious anti-tumor activity. However, AB is not available for clinical use due to its very low solubility and very short half-life. This study aimed to develop AB long sustained-release microspheres (ABMs) to improve the feasibility of clinical applica...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanqing, Huang, Weijuan, Wang, Nannan, Ouyang, Defang, Xiao, Lifeng, Zhang, Sirui, Ou, Xiaozheng, He, Tingsha, Yu, Rongmin, Song, Liyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399913/
https://www.ncbi.nlm.nih.gov/pubmed/34452197
http://dx.doi.org/10.3390/pharmaceutics13081236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399913/
https://www.ncbi.nlm.nih.gov/pubmed/34452197
http://dx.doi.org/10.3390/pharmaceutics13081236

Ejemplares similares